Zurcher Kantonalbank »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Zurcher Kantonalbank

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Zurcher Kantonalbank from 13F filings

Historical chart of Zurcher Kantonalbank investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Zurcher Kantonalbank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Zurcher Kantonalbank

Quarter filed Position value Share count Share price at filing
2024-03-31 $486k 500k 0.97
2023-12-31 $465k 500k 0.93
2023-09-30 $930k 1.0M 0.93

More positions owned by Zurcher Kantonalbank

Microsoft Corporation (MSFT)
Ubs Group SHS (UBS)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alcon Ord Shs (ALC)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Linde SHS (LIN)

View all positions for Zurcher Kantonalbank

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS
Readystate Asset Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1